MX366277B - Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas. - Google Patents
Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas.Info
- Publication number
- MX366277B MX366277B MX2015013254A MX2015013254A MX366277B MX 366277 B MX366277 B MX 366277B MX 2015013254 A MX2015013254 A MX 2015013254A MX 2015013254 A MX2015013254 A MX 2015013254A MX 366277 B MX366277 B MX 366277B
- Authority
- MX
- Mexico
- Prior art keywords
- dry particulate
- same
- topical formulations
- active agent
- agent compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Se proporcionan composiciones de retinoide particulado seco y fino adecuadas para usarse en formulaciones tópicas, así como los métodos para hacer las mismas; en las composiciones de retinoides particulado, el agente activo de retinoide está asociado con las partículas, es decir, a través de atrapamiento de las partículas en los poros y/o enlace jónico y/o enlace no covalente de las partículas a la superficie y/o holgadamente asociado con las partículas; también se proporcionan formulaciones tópicas que incluyen las composiciones de retinoide particulado seco de la invención, y métodos para usar las mismas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361798758P | 2013-03-15 | 2013-03-15 | |
US201461938080P | 2014-02-10 | 2014-02-10 | |
PCT/US2014/029673 WO2014145034A1 (en) | 2013-03-15 | 2014-03-14 | Fine dry particulate retinoid active agent compositions and topical formulations including the same |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015013254A MX2015013254A (es) | 2016-04-15 |
MX366277B true MX366277B (es) | 2019-07-04 |
Family
ID=51528082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015013254A MX366277B (es) | 2013-03-15 | 2014-03-14 | Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas. |
Country Status (16)
Country | Link |
---|---|
US (5) | US20140271879A1 (es) |
EP (1) | EP2968157B1 (es) |
JP (1) | JP2016514694A (es) |
KR (1) | KR20150131285A (es) |
CN (2) | CN105358135A (es) |
AU (1) | AU2014233420A1 (es) |
BR (1) | BR112015023117A2 (es) |
CA (1) | CA2906838A1 (es) |
CL (1) | CL2015002688A1 (es) |
EA (1) | EA201591826A1 (es) |
ES (1) | ES2975482T3 (es) |
MX (1) | MX366277B (es) |
MY (1) | MY183106A (es) |
NZ (1) | NZ713342A (es) |
SG (1) | SG11201507667SA (es) |
WO (1) | WO2014145034A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112012006635B8 (pt) * | 2008-09-23 | 2021-05-25 | Laboratory Skin Care Inc | composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas |
EA201591826A1 (ru) * | 2013-03-15 | 2016-01-29 | Лаборатори Скин Кеар, Инк. | Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения |
KR20170083068A (ko) * | 2014-11-03 | 2017-07-17 | 스텔라 앤드 닷 엘엘씨 | 피부관리 제제 및 요법 |
US11103465B2 (en) | 2017-11-22 | 2021-08-31 | Ted's Brain Science, Inc. | Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof |
CN113181073B (zh) * | 2021-04-30 | 2022-12-23 | 广州市科能化妆品科研有限公司 | 一种复合维生素乳液、祛皱精华霜及其制备方法 |
WO2024045049A1 (en) * | 2022-08-31 | 2024-03-07 | L'oreal | Composition for caring for keratin materials and mask containing the same |
CN115820338A (zh) * | 2023-02-22 | 2023-03-21 | 中国科学院昆明植物研究所 | 一种脱臭青刺果油的制备方法及其应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5559149A (en) * | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
FR2717686B1 (fr) * | 1994-03-22 | 1996-06-28 | Fabre Pierre Cosmetique | Composition dermo-cosmétologique et procédé de préparation. |
US6096324A (en) * | 1995-06-13 | 2000-08-01 | Laboratory Skin Care | Methods of delivering materials into the skin, and compositions used therein |
US5851538A (en) * | 1995-12-29 | 1998-12-22 | Advanced Polymer Systems, Inc. | Retinoid formulations in porous microspheres for reduced irritation and enhanced stability |
FR2774907B1 (fr) * | 1998-02-19 | 2000-05-12 | Luc Dewandre | Nouvelle formulation topique a base de retinaldehyde |
US6358517B1 (en) * | 1999-10-22 | 2002-03-19 | Unilever Home & Personal Care Usa, Division Of Conopco | Cosmetic compositions containing resveratrol and retinoids |
DE10233740A1 (de) * | 2002-07-24 | 2004-02-05 | Basf Ag | Retinoid-haltige Zubereitungen |
US20040180091A1 (en) * | 2003-03-13 | 2004-09-16 | Chang-Yi Lin | Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
WO2005037267A1 (ja) * | 2003-10-15 | 2005-04-28 | Ltt Bio-Pharma Co., Ltd. | 多価金属無機塩被覆レチノイン酸ナノ粒子の粒径の調整方法および当該調整方法により得られたナノ粒子 |
JPWO2009096481A1 (ja) * | 2008-01-30 | 2011-05-26 | Tbcグループ株式会社 | 皮膚外用組成物および美白化粧料 |
BR112012006635B8 (pt) * | 2008-09-23 | 2021-05-25 | Laboratory Skin Care Inc | composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas |
WO2010050980A1 (en) * | 2008-10-31 | 2010-05-06 | Laboratory Skin Care, Inc. | Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers |
ES2942923T3 (es) * | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
ES2932160T3 (es) * | 2009-11-10 | 2023-01-13 | Laboratory Skin Care Inc | Composiciones de protección solar que comprenden partículas de fosfato de calcio uniformes, rígidas, esféricas y nanoporosas y métodos para fabricar y utilizar las mismas |
EA201591826A1 (ru) * | 2013-03-15 | 2016-01-29 | Лаборатори Скин Кеар, Инк. | Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения |
WO2019068096A1 (en) * | 2017-09-29 | 2019-04-04 | Rodan & Fields, Llc | COMPOSITIONS CONTAINING RETINALDEHYDE AND METHODS OF USE |
-
2014
- 2014-03-14 EA EA201591826A patent/EA201591826A1/ru unknown
- 2014-03-14 NZ NZ713342A patent/NZ713342A/en unknown
- 2014-03-14 JP JP2016503189A patent/JP2016514694A/ja active Pending
- 2014-03-14 BR BR112015023117A patent/BR112015023117A2/pt not_active IP Right Cessation
- 2014-03-14 EP EP14763372.1A patent/EP2968157B1/en active Active
- 2014-03-14 CA CA2906838A patent/CA2906838A1/en active Pending
- 2014-03-14 ES ES14763372T patent/ES2975482T3/es active Active
- 2014-03-14 AU AU2014233420A patent/AU2014233420A1/en not_active Abandoned
- 2014-03-14 KR KR1020157029340A patent/KR20150131285A/ko not_active Application Discontinuation
- 2014-03-14 WO PCT/US2014/029673 patent/WO2014145034A1/en active Application Filing
- 2014-03-14 MY MYPI2015002380A patent/MY183106A/en unknown
- 2014-03-14 CN CN201480025309.4A patent/CN105358135A/zh active Pending
- 2014-03-14 US US14/214,429 patent/US20140271879A1/en not_active Abandoned
- 2014-03-14 MX MX2015013254A patent/MX366277B/es active IP Right Grant
- 2014-03-14 SG SG11201507667SA patent/SG11201507667SA/en unknown
- 2014-03-14 CN CN202011077617.5A patent/CN112263549A/zh active Pending
-
2015
- 2015-09-14 CL CL2015002688A patent/CL2015002688A1/es unknown
-
2016
- 2016-03-31 US US15/087,565 patent/US20160317469A1/en not_active Abandoned
-
2017
- 2017-08-17 US US15/680,055 patent/US20180028469A1/en not_active Abandoned
-
2020
- 2020-01-21 US US16/747,946 patent/US20200222336A1/en not_active Abandoned
-
2021
- 2021-03-05 US US17/193,366 patent/US20210259991A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2968157B1 (en) | 2023-11-08 |
WO2014145034A1 (en) | 2014-09-18 |
CN112263549A (zh) | 2021-01-26 |
ES2975482T3 (es) | 2024-07-08 |
US20180028469A1 (en) | 2018-02-01 |
AU2014233420A8 (en) | 2015-11-26 |
EA201591826A1 (ru) | 2016-01-29 |
CL2015002688A1 (es) | 2016-04-08 |
NZ713342A (en) | 2020-12-18 |
SG11201507667SA (en) | 2015-10-29 |
AU2014233420A1 (en) | 2015-11-12 |
MY183106A (en) | 2021-02-15 |
US20200222336A1 (en) | 2020-07-16 |
CN105358135A (zh) | 2016-02-24 |
KR20150131285A (ko) | 2015-11-24 |
JP2016514694A (ja) | 2016-05-23 |
BR112015023117A2 (pt) | 2017-07-18 |
US20210259991A1 (en) | 2021-08-26 |
US20140271879A1 (en) | 2014-09-18 |
MX2015013254A (es) | 2016-04-15 |
CA2906838A1 (en) | 2014-09-18 |
EP2968157A1 (en) | 2016-01-20 |
EP2968157A4 (en) | 2016-12-14 |
US20160317469A1 (en) | 2016-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015013254A (es) | Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas. | |
SA517381828B1 (ar) | Cftr مركبات، وتركيبات، وطرق لزيادة نشاط | |
PH12016500642A1 (en) | Selective substituted quinoline compounds | |
UA113440C2 (xx) | Сполуки тетрагідропіразолопіримідину | |
MX2015009105A (es) | Composiciones en solucion solida y su uso en inflamacion cronica. | |
MX2021015825A (es) | Formulaciones de anticuerpos estables acuosas. | |
EA201690280A1 (ru) | Композиции и способы, относящиеся к выделенным эндофитам | |
GB2535876A (en) | Absorbent clumping animal litter compositions | |
WO2014159669A3 (en) | Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions | |
MX2016008150A (es) | Formulaciones de berberina y usos de las mismas. | |
MX2015016410A (es) | Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos. | |
GB2514741A (en) | Composition for use as a paint binder | |
PL2989192T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
PH12015502717A1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
MX2016002930A (es) | Moduladores del receptor x hepatico (lxr). | |
EA201492280A1 (ru) | Стабильный состав пексиганана | |
MY175420A (en) | Fine dry particulate resveratrol active agent compositions and topical formulations including the same | |
FI20136136A (fi) | Menetelmä kosmeettisten koostumusten valmistamiseksi, kosmeettiset koostumukset sekä niiden käyttö | |
ES2426017A2 (es) | Microemulsión que comprende colagenasa y usos | |
IN2013MU03429A (es) | ||
UA78375U (ru) | Применение сорбента "силикс" как антисептического и вяжущего средства | |
IN2013MU02486A (es) | ||
AR100593A1 (es) | Composición sinérgica surfactante | |
MX2016001694A (es) | Formulacion de vacuna de sacarido. | |
EA201500559A1 (ru) | Композиция, включающая теанин и экстракт девясила кистевидного |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |